Company / Net Income
Arcadia Biosciences, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$7.0M
FY2025
5-year range
-$15.4M / -$4.7M
FY2021-FY2025
Trend
+49.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has fluctuated over the past 10 years, ranging from -$29M in FY2020 to -$5M in FY2021.
Based on SEC 10-K filings.
-$7M in FY2025.
Improved from -$15M to -$7M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 49.7% year-over-year.
- Peak net income was recorded in FY2021.
- Lowest net income in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$7.0M | +49.7% |
| FY2024 | -$14.0M | +9.1% |
| FY2023 | -$15.4M | -4.9% |
| FY2022 | -$14.7M | -214.9% |
| FY2021 | -$4.7M | +83.8% |
| FY2020 | -$28.8M | -113.7% |
| FY2019 | -$13.5M | +14.2% |
| FY2018 | -$15.7M | +20.0% |
| FY2017 | -$19.6M | -9.3% |
| FY2016 | -$18.0M | +2.1% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026